Nifedipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related …

EM Sorkin, SP Clissold, RN Brogden - Drugs, 1985 - Springer
Nifedipine 1 is an antagonist of calcium influx through the slow channel of the cell
membrane and has been shown to be an effective and relatively well-tolerated treatment for …

Captopril: an update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

RN Brogden, PA Todd, EM Sorkin - Drugs, 1988 - Springer
Captopril is an orally active inhibitor of angiotensin-converting enzyme (ACE) and has been
widely studied in the treatment of patients with mild to moderate essential hypertension …

Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril

JT Wright, JK Dunn, JA Cutler, BR Davis, WC Cushman… - Jama, 2005 - jamanetwork.com
ContextFew cardiovascular outcome data are available for blacks with hypertension treated
with angiotensin-converting enzyme (ACE) inhibitors or calcium channel blockers (CCBs) …

Angiotensin converting enzyme inhibitors and moderate hypertension

D McAreavey, JIS Robertson - Drugs, 1990 - Springer
Recently there has been extensive development of orally active angiotensin converting
enzyme (ACE) inhibitors in addition to those already marketed, for example, captopril …

Drug therapy for resistant hypertension: simplifying the approach

SJ Mann - The Journal of Clinical Hypertension, 2011 - Wiley Online Library
Despite the availability of many effective antihypertensive drugs, the drug therapy for
resistant hypertension remains a prominent problem. Reviews offer only the general …

ACE inhibitors: drug interactions of clinical significance

C Mignat, T Unger - Drug safety, 1995 - Springer
ACE inhibitors are used widely in the treatment of hypertension and congestive heart failure,
but there is only limited information on adverse interactions between ACE inhibitors and …

[HTML][HTML] ACE inhibitors in renal disease

HR Brunner - Kidney international, 1992 - Elsevier
Patient 1. A 46-year-old school teacher went to his family physician because of a nose
bleed. He had suffered from frequent headaches for the previous 15 years and during the …

The place of combination therapy in the treatment of hypertension in 1993

J Chalmers - Clinical and Experimental Hypertension, 1993 - Taylor & Francis
“Step Care” fell into disuse following the advent of the ACE inhibitors and calcium
antagonists. This was partly because the potency of these agents encouraged their use in …

Enalapril and atenolol in essential hypertension: attenuation of hypotensive effects in combination

LMH Wing, JP Chalmers, MJ West… - … Hypertension. Part A …, 1988 - Taylor & Francis
In 16 patients with essential hypertension the effects of enalapril 20 mg once daily were
compared with those of atenolol 50 mg once daily, with the two drugs in combination and …

Combination of β adrenergic receptor block and renin–angiotensin system inhibition diminished the angiotensin II-induced vasoconstriction and increased bradykinin …

D Lezama-Martínez, I Valencia-Hernández… - Dose …, 2017 - journals.sagepub.com
In hypertension, the combination therapy is frequently used to obtain a better therapeutic
effect and reduce adverse effects. One effective combination is with inhibitors and β-blockers …